领航医药生物科技(00399.HK)向主要股东悉售所持精优药业(00858.HK)持股及CB总代价2.7亿元

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

领航医药生物科技(00399.HK)向主要股东悉售所持精优药业(00858.HK)持股及CB总代价2.7亿元

阿思达克 06-25 09:36

领航医药生物科技(00399.HK)公布，以总代价2.7亿元向主要股东毛裕民出售精优药业(00858.HK)近4.58亿股，及精优药业所发行本金额5.77亿元之可换股债券，有关债券可按每股0.6413元转换为精优药业9亿股。

待售股份相当於精优药业19.14%股权，其为公司的联营公司。紧随出售事项後，公司将不再持有精优药业任何股份及可换股债券。公司续停牌。

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

领航医药生物科技(00399.HK)向主要股东悉售所持精优药业(00858.HK)持股及CB总代价2.7亿元

Services

About Us

Agreement Statement